Pharming Group N.V. - ADR

Pharming Group N.V. - ADR

PHAR

Get informed when a big investor buys or sells

+ Follow
Market Cap$775.02M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Pharming Group N.V. - ADRPharming Group N.V. - ADR75.5-3%2.40.4
$40.00

Target Price by Analysts

238.1% upsidePharming Group N.V. Target Price DetailsTarget Price
$15.82

Current Fair Value

33.7% upside

Undervalued by 33.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$775.02 Million
Enterprise Value$730.03 Million
Dividend Yield$- (-)
Earnings per Share$0.04
Beta0.09
Outstanding Shares70,140,400

Return

Return on Equity3.13%ROE
Return on Assets1.81%
Return on Invested Capital1662.21%

Valuation & Multiples

P/E Ratio75.49P/E Ratio
PEG-116.43PEG
Price to Sales2.37Price to Sales
Price to Book Ratio3.94Price to Book Ratio
Enterprise Value to Revenue2.08
Enterprise Value to EBIT0.12
Enterprise Value to Net Income86
Total Debt to Enterprise0.16
Debt to Equity0.42Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 30, 2026
EPS Estimate
$0.06
Average shareholder expectation
Revenue Estimate
$99.52 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$0.10
Average shareholder expectation
Revenue Estimate
$106.06 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.09%▼ 0.03%
Total Invested$897,098▼ 36.55%
Investors Holding5▼ 7.00%

ESG Score

No data

About Pharming Group N.V.

CEO: Sijmen de Vries